APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gadoterate Meglumine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Gadoterate Meglumine Market Outlook and Growth Opportunities 2026

19 December 2025195 pages

Choose your research edition.

Industry ResearchGadoterate Meglumine Industry Research Report 2026109 pages · $2,950 USDIndustry Growth & TrendsGlobal Gadoterate Meglumine Industry Growth and Trends Forecast to 203276 pages · $3,450 USDMarket StructureGlobal Gadoterate Meglumine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032171 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gadoterate Meglumine Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Gadoterate Meglumine Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Gadoterate Meglumine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Gadoterate Meglumine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Gadoterate Meglumine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gadoterate Meglumine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Gadoterate Meglumine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Gadoterate Meglumine market include Hengrui Medicine, Guerbet Group and GE Healthcare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Gadoterate Meglumine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Gadoterate Meglumine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Gadoterate Meglumine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Gadoterate Meglumine market size, projected growth trends, production technologies, key applications, and end-use industries.

Gadoterate Meglumine Segment by Company

Hengrui Medicine

Guerbet Group

GE Healthcare

Gadoterate Meglumine Segment by Type

5.6535Gm/15Ml

3.769Gm/10Ml

1.8845Gm/5Ml

Others

Gadoterate Meglumine Segment by Application

Hospitals

Clinics

Gadoterate Meglumine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Gadoterate Meglumine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Gadoterate Meglumine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Gadoterate Meglumine significant trends, drivers, influence factors in global and regions.

6. To analyze Gadoterate Meglumine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gadoterate Meglumine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gadoterate Meglumine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gadoterate Meglumine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Gadoterate Meglumine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gadoterate Meglumine industry.

Chapter 3: Detailed analysis of Gadoterate Meglumine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Gadoterate Meglumine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Gadoterate Meglumine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Gadoterate Meglumine Industry Trends Table 2. Gadoterate Meglumine Industry Drivers Table 3. Gadoterate Meglumine Industry Opportunities and Challenges Table 4. Gadoterate Meglumine Industry Restraints Table 5. Global Gadoterate Meglumine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Gadoterate Meglumine Revenue Share by Company (2021-2026) Table 7. Global Gadoterate Meglumine Sales Volume by Company (K L) & (2021-2026) Table 8. Global Gadoterate Meglumine Sales Volume Share by Company (2021-2026) Table 9. Global Gadoterate Meglumine Average Price (US$/L) of Company (2021-2026) Table 10. Global Gadoterate Meglumine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Gadoterate Meglumine Key Company Manufacturing Base & Headquarters Table 12. Global Gadoterate Meglumine Company, Product Type & Application Table 13. Global Gadoterate Meglumine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Gadoterate Meglumine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 5.6535Gm/15Ml Table 18. Significant Companies of 3.769Gm/10Ml Table 19. Significant Companies of 1.8845Gm/5Ml Table 20. Significant Companies of Others Table 21. Global Gadoterate Meglumine Sales Volume by Type 2021 VS 2025 VS 2032 (K L) Table 22. Global Gadoterate Meglumine Sales Volume by Type (2021-2026) & (K L) Table 23. Global Gadoterate Meglumine Sales Volume by Type (2027-2032) & (K L) Table 24. Global Gadoterate Meglumine Sales Volume Share by Type (2021-2026) Table 25. Global Gadoterate Meglumine Sales Volume Share by Type (2027-2032) Table 26. Global Gadoterate Meglumine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Gadoterate Meglumine Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Gadoterate Meglumine Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Gadoterate Meglumine Sales Value Share by Type (2021-2026) Table 30. Global Gadoterate Meglumine Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Hospitals Table 32. Significant Companies of Clinics Table 33. Global Gadoterate Meglumine Sales Volume by Application 2021 VS 2025 VS 2032 (K L) Table 34. Global Gadoterate Meglumine Sales Volume by Application (2021-2026) & (K L) Table 35. Global Gadoterate Meglumine Sales Volume by Application (2027-2032) & (K L) Table 36. Global Gadoterate Meglumine Sales Volume Share by Application (2021-2026) Table 37. Global Gadoterate Meglumine Sales Volume Share by Application (2027-2032) Table 38. Global Gadoterate Meglumine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Gadoterate Meglumine Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Gadoterate Meglumine Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Gadoterate Meglumine Sales Value Share by Application (2021-2026) Table 42. Global Gadoterate Meglumine Sales Value Share by Application (2027-2032) Table 43. Global Gadoterate Meglumine Sales by Region: 2021 VS 2025 VS 2032 (K L) Table 44. Global Gadoterate Meglumine Sales by Region (2021-2026) & (K L) Table 45. Global Gadoterate Meglumine Sales Market Share by Region (2021-2026) Table 46. Global Gadoterate Meglumine Sales by Region (2027-2032) & (K L) Table 47. Global Gadoterate Meglumine Sales Market Share by Region (2027-2032) Table 48. Global Gadoterate Meglumine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Gadoterate Meglumine Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Gadoterate Meglumine Sales Value Share by Region (2021-2026) Table 51. Global Gadoterate Meglumine Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Gadoterate Meglumine Sales Value Share by Region (2027-2032) Table 53. Global Gadoterate Meglumine Market Average Price (US$/L) by Region (2021-2026) Table 54. Global Gadoterate Meglumine Market Average Price (US$/L) by Region (2027-2032) Table 55. Global Gadoterate Meglumine Sales by Country: 2021 VS 2025 VS 2032 (K L) Table 56. Global Gadoterate Meglumine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Gadoterate Meglumine Sales by Country (2021-2026) & (K L) Table 58. Global Gadoterate Meglumine Sales Market Share by Country (2021-2026) Table 59. Global Gadoterate Meglumine Sales by Country (2027-2032) & (K L) Table 60. Global Gadoterate Meglumine Sales Market Share by Country (2027-2032) Table 61. Global Gadoterate Meglumine Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Gadoterate Meglumine Sales Value Market Share by Country (2021-2026) Table 63. Global Gadoterate Meglumine Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Gadoterate Meglumine Sales Value Market Share by Country (2027-2032) Table 65. Hengrui Medicine Company Information Table 66. Hengrui Medicine Business Overview Table 67. Hengrui Medicine Gadoterate Meglumine Sales (K L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 68. Hengrui Medicine Gadoterate Meglumine Product Portfolio Table 69. Hengrui Medicine Recent Development Table 70. Guerbet Group Company Information Table 71. Guerbet Group Business Overview Table 72. Guerbet Group Gadoterate Meglumine Sales (K L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 73. Guerbet Group Gadoterate Meglumine Product Portfolio Table 74. Guerbet Group Recent Development Table 75. GE Healthcare Company Information Table 76. GE Healthcare Business Overview Table 77. GE Healthcare Gadoterate Meglumine Sales (K L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 78. GE Healthcare Gadoterate Meglumine Product Portfolio Table 79. GE Healthcare Recent Development Table 80. Key Raw Materials Table 81. Raw Materials Key Suppliers Table 82. Gadoterate Meglumine Distributors List Table 83. Gadoterate Meglumine Customers List Table 84. Research Programs/Design for This Report Table 85. Authors List of This Report Table 86. Secondary Sources Table 87. Primary Sources List of Figures Figure 1. Gadoterate Meglumine Product Image Figure 2. Global Gadoterate Meglumine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gadoterate Meglumine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Gadoterate Meglumine Sales (2021-2032) & (K L) Figure 5. Global Gadoterate Meglumine Sales Average Price (US$/L) & (2021-2032) Figure 6. Global Gadoterate Meglumine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 5.6535Gm/15Ml Image Figure 10. 3.769Gm/10Ml Image Figure 11. 1.8845Gm/5Ml Image Figure 12. Others Image Figure 13. Global Gadoterate Meglumine Sales Volume by Type (2021 VS 2025 VS 2032) & (K L) Figure 14. Global Gadoterate Meglumine Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Gadoterate Meglumine Sales Volume Share by Type (2021-2032) Figure 16. Global Gadoterate Meglumine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Gadoterate Meglumine Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Gadoterate Meglumine Sales Value Share by Type (2021-2032) Figure 19. Hospitals Image Figure 20. Clinics Image Figure 21. Global Gadoterate Meglumine Sales Volume by Application (2021 VS 2025 VS 2032) & (K L) Figure 22. Global Gadoterate Meglumine Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Gadoterate Meglumine Sales Volume Share by Application (2021-2032) Figure 24. Global Gadoterate Meglumine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Gadoterate Meglumine Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Gadoterate Meglumine Sales Value Share by Application (2021-2032) Figure 27. Global Gadoterate Meglumine Sales by Region: 2021 VS 2025 VS 2032 (K L) Figure 28. Global Gadoterate Meglumine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Gadoterate Meglumine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Gadoterate Meglumine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Gadoterate Meglumine Sales Value (2021-2032) & (US$ Million) Figure 32. North America Gadoterate Meglumine Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Gadoterate Meglumine Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Gadoterate Meglumine Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Gadoterate Meglumine Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Gadoterate Meglumine Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Gadoterate Meglumine Sales Value (2021-2032) & (US$ Million) Figure 38. South America Gadoterate Meglumine Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Gadoterate Meglumine Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Gadoterate Meglumine Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Gadoterate Meglumine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Gadoterate Meglumine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Gadoterate Meglumine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Gadoterate Meglumine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Gadoterate Meglumine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Gadoterate Meglumine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Gadoterate Meglumine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Gadoterate Meglumine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Gadoterate Meglumine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Gadoterate Meglumine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Gadoterate Meglumine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Gadoterate Meglumine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Gadoterate Meglumine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Gadoterate Meglumine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Gadoterate Meglumine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Gadoterate Meglumine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Gadoterate Meglumine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Gadoterate Meglumine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Gadoterate Meglumine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Gadoterate Meglumine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Gadoterate Meglumine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Gadoterate Meglumine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Gadoterate Meglumine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Gadoterate Meglumine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Gadoterate Meglumine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Gadoterate Meglumine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Gadoterate Meglumine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Gadoterate Meglumine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Gadoterate Meglumine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Gadoterate Meglumine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Gadoterate Meglumine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Gadoterate Meglumine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Gadoterate Meglumine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Gadoterate Meglumine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Gadoterate Meglumine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Gadoterate Meglumine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Gadoterate Meglumine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Gadoterate Meglumine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Gadoterate Meglumine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Gadoterate Meglumine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Gadoterate Meglumine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Gadoterate Meglumine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Gadoterate Meglumine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Gadoterate Meglumine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Gadoterate Meglumine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Gadoterate Meglumine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Gadoterate Meglumine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Gadoterate Meglumine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Gadoterate Meglumine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Gadoterate Meglumine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Gadoterate Meglumine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Gadoterate Meglumine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Gadoterate Meglumine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Gadoterate Meglumine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Gadoterate Meglumine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Gadoterate Meglumine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Gadoterate Meglumine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Gadoterate Meglumine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Gadoterate Meglumine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Gadoterate Meglumine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Gadoterate Meglumine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Gadoterate Meglumine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Gadoterate Meglumine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Gadoterate Meglumine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Gadoterate Meglumine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Gadoterate Meglumine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Gadoterate Meglumine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Gadoterate Meglumine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Gadoterate Meglumine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Gadoterate Meglumine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Gadoterate Meglumine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Gadoterate Meglumine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Gadoterate Meglumine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Gadoterate Meglumine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Gadoterate Meglumine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Gadoterate Meglumine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Gadoterate Meglumine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Gadoterate Meglumine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Gadoterate Meglumine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Gadoterate Meglumine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Gadoterate Meglumine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Gadoterate Meglumine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Gadoterate Meglumine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Gadoterate Meglumine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Gadoterate Meglumine Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Gadoterate Meglumine Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • 5.6535Gm/15Ml
  • 3.769Gm/10Ml
  • 1.8845Gm/5Ml
  • Others
Applications
  • Hospitals
  • Clinics
Companies covered
  • Hengrui Medicine
  • Guerbet Group
  • GE Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Gadoterate Meglumine Sales Value (2021-2032)
  4. 1.2.2 Global Gadoterate Meglumine Sales Volume (2021-2032)
  5. 1.2.3 Global Gadoterate Meglumine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Gadoterate Meglumine Market Dynamics
  1. 2.1 Gadoterate Meglumine Industry Trends
  2. 2.2 Gadoterate Meglumine Industry Drivers
  3. 2.3 Gadoterate Meglumine Industry Opportunities and Challenges
  4. 2.4 Gadoterate Meglumine Industry Restraints
3 Gadoterate Meglumine Market by Company
  1. 3.1 Global Gadoterate Meglumine Company Revenue Ranking in 2025
  2. 3.2 Global Gadoterate Meglumine Revenue by Company (2021-2026)
  3. 3.3 Global Gadoterate Meglumine Sales Volume by Company (2021-2026)
  4. 3.4 Global Gadoterate Meglumine Average Price by Company (2021-2026)
  5. 3.5 Global Gadoterate Meglumine Company Ranking (2024-2026)
  6. 3.6 Global Gadoterate Meglumine Company Manufacturing Base and Headquarters
  7. 3.7 Global Gadoterate Meglumine Company Product Type and Application
  8. 3.8 Global Gadoterate Meglumine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Gadoterate Meglumine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Gadoterate Meglumine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Gadoterate Meglumine Market by Type
  1. 4.1 Gadoterate Meglumine Type Introduction
  2. 4.1.1 5.6535Gm/15Ml
  3. 4.1.2 3.769Gm/10Ml
  4. 4.1.3 1.8845Gm/5Ml
  5. 4.1.4 Others
  6. 4.2 Global Gadoterate Meglumine Sales Volume by Type
  7. 4.2.1 Global Gadoterate Meglumine Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Gadoterate Meglumine Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Gadoterate Meglumine Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Gadoterate Meglumine Sales Value by Type
  11. 4.3.1 Global Gadoterate Meglumine Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Gadoterate Meglumine Sales Value by Type (2021-2032)
  13. 4.3.3 Global Gadoterate Meglumine Sales Value Share by Type (2021-2032)
5 Gadoterate Meglumine Market by Application
  1. 5.1 Gadoterate Meglumine Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.2 Global Gadoterate Meglumine Sales Volume by Application
  5. 5.2.1 Global Gadoterate Meglumine Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Gadoterate Meglumine Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Gadoterate Meglumine Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Gadoterate Meglumine Sales Value by Application
  9. 5.3.1 Global Gadoterate Meglumine Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Gadoterate Meglumine Sales Value by Application (2021-2032)
  11. 5.3.3 Global Gadoterate Meglumine Sales Value Share by Application (2021-2032)
6 Gadoterate Meglumine Regional Sales and Value Analysis
  1. 6.1 Global Gadoterate Meglumine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Gadoterate Meglumine Sales by Region (2021-2032)
  3. 6.2.1 Global Gadoterate Meglumine Sales by Region: 2021-2026
  4. 6.2.2 Global Gadoterate Meglumine Sales by Region (2027-2032)
  5. 6.3 Global Gadoterate Meglumine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Gadoterate Meglumine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Gadoterate Meglumine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Gadoterate Meglumine Sales Value by Region (2027-2032)
  9. 6.5 Global Gadoterate Meglumine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Gadoterate Meglumine Sales Value (2021-2032)
  12. 6.6.2 North America Gadoterate Meglumine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Gadoterate Meglumine Sales Value (2021-2032)
  15. 6.7.2 Europe Gadoterate Meglumine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Gadoterate Meglumine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Gadoterate Meglumine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Gadoterate Meglumine Sales Value (2021-2032)
  21. 6.9.2 South America Gadoterate Meglumine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Gadoterate Meglumine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Gadoterate Meglumine Sales Value Share by Country, 2025 VS 2032
7 Gadoterate Meglumine Country-level Sales and Value Analysis
  1. 7.1 Global Gadoterate Meglumine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Gadoterate Meglumine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Gadoterate Meglumine Sales by Country (2021-2032)
  4. 7.3.1 Global Gadoterate Meglumine Sales by Country (2021-2026)
  5. 7.3.2 Global Gadoterate Meglumine Sales by Country (2027-2032)
  6. 7.4 Global Gadoterate Meglumine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Gadoterate Meglumine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Gadoterate Meglumine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Gadoterate Meglumine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Gadoterate Meglumine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Gadoterate Meglumine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Gadoterate Meglumine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Gadoterate Meglumine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Gadoterate Meglumine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Gadoterate Meglumine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Gadoterate Meglumine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Gadoterate Meglumine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Gadoterate Meglumine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Gadoterate Meglumine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Gadoterate Meglumine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Gadoterate Meglumine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Gadoterate Meglumine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Gadoterate Meglumine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Gadoterate Meglumine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Gadoterate Meglumine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Gadoterate Meglumine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Gadoterate Meglumine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Gadoterate Meglumine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Gadoterate Meglumine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Gadoterate Meglumine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Gadoterate Meglumine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Gadoterate Meglumine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Gadoterate Meglumine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Gadoterate Meglumine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Gadoterate Meglumine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Gadoterate Meglumine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Gadoterate Meglumine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Gadoterate Meglumine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Gadoterate Meglumine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Gadoterate Meglumine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Gadoterate Meglumine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Gadoterate Meglumine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Gadoterate Meglumine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Gadoterate Meglumine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Gadoterate Meglumine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Gadoterate Meglumine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Gadoterate Meglumine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Gadoterate Meglumine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Gadoterate Meglumine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Gadoterate Meglumine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Gadoterate Meglumine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Gadoterate Meglumine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Gadoterate Meglumine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Gadoterate Meglumine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Gadoterate Meglumine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Gadoterate Meglumine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Gadoterate Meglumine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Gadoterate Meglumine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Gadoterate Meglumine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Gadoterate Meglumine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Gadoterate Meglumine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Gadoterate Meglumine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Gadoterate Meglumine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Gadoterate Meglumine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Gadoterate Meglumine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Gadoterate Meglumine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Gadoterate Meglumine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Gadoterate Meglumine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Gadoterate Meglumine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Gadoterate Meglumine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Gadoterate Meglumine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Gadoterate Meglumine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Gadoterate Meglumine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Gadoterate Meglumine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Gadoterate Meglumine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Gadoterate Meglumine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Gadoterate Meglumine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Gadoterate Meglumine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Gadoterate Meglumine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Gadoterate Meglumine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Gadoterate Meglumine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Gadoterate Meglumine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Gadoterate Meglumine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Gadoterate Meglumine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Gadoterate Meglumine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Gadoterate Meglumine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Gadoterate Meglumine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Gadoterate Meglumine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Gadoterate Meglumine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Gadoterate Meglumine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Gadoterate Meglumine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Gadoterate Meglumine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Hengrui Medicine
  2. 8.1.1 Hengrui Medicine Company Information
  3. 8.1.2 Hengrui Medicine Business Overview
  4. 8.1.3 Hengrui Medicine Gadoterate Meglumine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Hengrui Medicine Gadoterate Meglumine Product Portfolio
  6. 8.1.5 Hengrui Medicine Recent Developments
  7. 8.2 Guerbet Group
  8. 8.2.1 Guerbet Group Company Information
  9. 8.2.2 Guerbet Group Business Overview
  10. 8.2.3 Guerbet Group Gadoterate Meglumine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Guerbet Group Gadoterate Meglumine Product Portfolio
  12. 8.2.5 Guerbet Group Recent Developments
  13. 8.3 GE Healthcare
  14. 8.3.1 GE Healthcare Company Information
  15. 8.3.2 GE Healthcare Business Overview
  16. 8.3.3 GE Healthcare Gadoterate Meglumine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 GE Healthcare Gadoterate Meglumine Product Portfolio
  18. 8.3.5 GE Healthcare Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Gadoterate Meglumine Value Chain Analysis
  2. 9.1.1 Gadoterate Meglumine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Gadoterate Meglumine Sales Mode & Process
  6. 9.2 Gadoterate Meglumine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Gadoterate Meglumine Distributors
  9. 9.2.3 Gadoterate Meglumine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst